S
Stephen S. Arnon
Researcher at California Health and Human Services Agency
Publications - 33
Citations - 3669
Stephen S. Arnon is an academic researcher from California Health and Human Services Agency. The author has contributed to research in topics: Infant Botulism & Botulism. The author has an hindex of 23, co-authored 32 publications receiving 3517 citations. Previous affiliations of Stephen S. Arnon include Oklahoma State Department of Health.
Papers
More filters
Journal ArticleDOI
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Stephen S. Arnon,Robert Schechter,Thomas V. Inglesby,Donald A. Henderson,John G. Bartlett,Michael S. Ascher,Edward M. Eitzen,Anne D. Fine,Jerome Hauer,Marcelle Layton,Scott R. Lillibridge,Michael T. Osterholm,Tara O'Toole,Gerald W. Parker,Trish M. Perl,Philip K. Russell,David L. Swerdlow,Kevin Tonat +17 more
TL;DR: People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months.
Journal ArticleDOI
Human botulism immune globulin for the treatment of infant botulism.
TL;DR: Infants treated with BIG-IV had a reduction in the mean length of the hospital stay, the primary efficacy outcome measure, from 5.7 weeks to 2.6 weeks, compared with the control group in the randomized trial.
Journal ArticleDOI
Honey and other environmental risk factors for infant botulism.
TL;DR: Honey is now an identified and avoidable source of C. botulinum spores, and it therefore should not be fed to infants, and is significantly associated with type B infant botulism.
Journal Article
Botulinum toxin as a biological weapon
Stephen S. Arnon,Robert Schechter,Thomas V. Inglesby,Donald A. Henderson,John G. Bartlett,Michael S. Ascher,Edward M. Eitzen,Anne D. Fine,Jerome Hauer,Marcelle Layton,Scott R. Lillibridge,Michael T. Osterholm,Tara O'Toole,Gerald W. Parker,Trish M. Perl,Philip K. Russell,David L. Swerdlow,Kevin Tonat +17 more
TL;DR: A strategic plan for preparedness and response to biological and chemical terrorism and its impact on health and safety is recommended by the CDC Strategic Planning Workgroup.
Journal ArticleDOI
Infant botulism. Epidemiological, clinical, and laboratory aspects.
TL;DR: Clostridium botulinum organisms and toxin were identified in the feces of six infants, aged 5 to 20 weeks, who had illnesses clinically consistent with botulism, and a characteristic electromyographic pattern termed "brief, small, abundant, motor-unit action potentials" was observed.